InsiderTrades

Form 4 for CRVS Corvus Pharmaceuticals, Inc.

Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001567619-22-013465 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-06-28 2022-06-24+ CRVS MILLER RICHARD A MD Pres, CEO, Dir P - Purchase $1.01 +10.0K 1.35M +0.7% +$10.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-24 P A 5,000 $1.03 1,344,405 I By Trust — — (F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
2 Common Common Stock 2022-06-27 P A 5,000 $1.00 1,349,405 I By Trust — — (F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.